Echo45 Advisors LLC Vista Gen Therapeutics, Inc. Transaction History

Echo45 Advisors LLC

  • $145 Million
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 26, 2023
SELL
$0.12 - $0.3 $312 - $781
-2,604 Reduced 16.64%
13,043 $1,000
Q4 2022

Jan 30, 2023
BUY
$0.09 - $4.8 $1,408 - $75,105
15,647 New
15,647 $1,000

Others Institutions Holding VTGN

# of Institutions
1
Shares Held
27.1K
Call Options Held
0
Put Options Held
0
View Full List

About VistaGen Therapeutics, Inc.

VTGN Quotes by TradingView
  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $610M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Echo45 Advisors LLC Portfolio

Follow Echo45 Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Echo45 Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Echo45 Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email